How digitally mature is pharma?
What progress has pharma made to embrace the digital age? Are digital strategies robust enough? Are appropriate capabilities and organisational structures in place? How culturally ready is the industry for the lightning-fast pace of technology?
Our professional researchers carried out a deep dive into the current state of pharma digital transformation to find out if and how digital opportunities are being exploited – or if stagnation has set in. We carried out in-depth interviews with 8 senior digital and data experts and discussed the key issues and challenges, including:
What to expect from this report
More than just an assessment of the current state of play, this report crucially provides the key insights and recommendations needed to accelerate progress and come out ahead of the rest. Now you can download The State of Pharma Digital Transformation for the very latest views on progress, up-to-date examples, plus clear guidance from leading experts on how best to proceed.
How did we do it?
Example insight included in The State of Pharma Digital Transformation
"The large pools of data being generated from digital tools is both an opportunity and a challenge. Mass data pools are providing pharma with opportunities they cannot yet fully reap due to poor data management processes. The volume of data will not slow down; but is likely to accelerate. Therefore, pharma must act quickly in terms of building core internal digital capabilities and moving beyond their traditional IT functions. They need a complete IT revamp that can cope with the digital world if they are to progress their transformation."
Example quote included in The State of Pharma Digital Transformation
"A lot of senior leaders are very interested in the cutting-edge technologies, like artificial intelligence and chatbots, and while that's truly interesting I think sometimes we should not forget the fundamentals. You need competencies and teams that understand the digital opportunities and can work to execute them before you begin to talk about some of the more high-level technology. If I were to give advice to senior executives, I would say to make sure you get the fundamentals in place before you jump on to the fancy digital solutions."
Kasper Jerlang, Head of Global Digital Marketing and Engagement at LEO Pharma
The expert panel for The State of Pharma Digital Transformation
Why buy now?
No one disputes the importance of a digital transformation, but there are still very different viewpoints and levels of understanding on what is needed to achieve success. And without any consensus on what a digitally mature pharma business might look like, it's impossible to embed the organisational and cultural changes needed to make real progress. Digital transformation is more than simply trying some new digital tools. Clearly, bold leadership is needed: this is not the time for a conservative approach to change.
Why FirstWord reports are different
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved